Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Breaking Down the Positive Findings of Phase III Trial for Prostate Cancer Drug

php logoMark Wildgust, PhD, vice president, medical affairs/oncology, Janssen, discusses the results of the SPARTAN study that examined use of Erleada (apalutamide) for the treatment of prostate cancer, and highlights how the findings of this study impacts the future of care. 

 

Advertisement

Advertisement

Advertisement